TH165767A - Substituteed compound Dihydroisokinolinone - Google Patents
Substituteed compound DihydroisokinolinoneInfo
- Publication number
- TH165767A TH165767A TH1601007481A TH1601007481A TH165767A TH 165767 A TH165767 A TH 165767A TH 1601007481 A TH1601007481 A TH 1601007481A TH 1601007481 A TH1601007481 A TH 1601007481A TH 165767 A TH165767 A TH 165767A
- Authority
- TH
- Thailand
- Prior art keywords
- salts
- compounds
- compound
- formula
- dihydroisokinolinone
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract 8
- 150000003839 salts Chemical class 0.000 claims abstract 7
- 239000011780 sodium chloride Substances 0.000 claims abstract 7
- 230000002159 abnormal effect Effects 0.000 claims abstract 2
- 201000011510 cancer Diseases 0.000 claims abstract 2
- 230000010261 cell growth Effects 0.000 claims abstract 2
- 239000000470 constituent Substances 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims 1
Abstract
การประดิษร์นี้เกี่ยวกับสารประกอบของสูตรทั่วไป (I) (สูตร) (I), ซึ่ง R1, R2, R3, R4, L, X และ Z เป็นตามที่นิยามไว้ในที่นี้, และเกลือของมันที่เป็นที่ยอมรับเชิง เภสัชกรรม,กับองค์ประกอบทางเภสัชกรรมซึ่งประกอบรวมด้วยสารประกอบและเกลือดังกล่าว, และ กับวิธีการใช้สารประกอบ, เกลือและองค์ประกอบดังกล่าวสำหรับการบำบัดการเจริญเติบโตของเซลล์ ที่ผิดปกติ, ซึ่งรวมถึงมะเร็ง สิทธิบัตรยา This writing is about compounds of general formulas (I) (formula) (I), where R1, R2, R3, R4, L, X and Z are defined here, and their salts that are Accepted Pharmacy, with pharmaceutical constituents comprising such compounds and salts, and with methods for using those compounds, salts and elements for the treatment of abnormal cell growth, including cancer, drug patents.
Claims (1)
Publications (2)
Publication Number | Publication Date |
---|---|
TH165767A true TH165767A (en) | 2017-08-10 |
TH165767B TH165767B (en) | 2017-08-10 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016501813A1 (en) | 1,3-benzodioxole derivative | |
ECSP17010481A (en) | NEW 2,5-SUBSTITUTED PYRIMIDINES | |
SA518390920B1 (en) | Novel annelated phenoxyacetamides | |
ECSP17010482A (en) | NEW 2,5-SUBSTITUTED PYRIMIDINES | |
EA201591649A1 (en) | COMPOSITIONS WITH ORGANIC COMPOUNDS | |
EA201692270A1 (en) | DERIVATIVES OF NAFTYRIDINDIONE | |
TH165767A (en) | Substituteed compound Dihydroisokinolinone | |
TH165767B (en) | Substituteed compound Dihydroisokinolinone | |
TH174458A (en) | Pharmaceutical solids containing biotherin derivatives And the use of such elements | |
TH1601004492A (en) | New tetrahydropyridopyrimidine compounds or their salts | |
TH1901002344A (en) | Novel naphthyridone derivatives and their use in the treatment of cardiac arrhythmias. | |
TH170537A (en) | Chemical compound | |
TH168624A (en) | Glucopyranosil-substrate derivatives Indole-urea And the use of those substances As an SGLT inhibitor | |
TH182729A (en) | Phenoxymethyl derivatives | |
TH1801001230A (en) | Pyrazolo[3,4-d] new pyrimidine compounds or their salts | |
TH154821A (en) | Fudge ring quinolil pyrolopyrimidil compound Or the salt of this substance | |
TH168956A (en) | MEK inhibitors and compounds | |
TH1801001807A (en) | An isoindolinone inhibitor of MDM2-P53 interaction with anticancer activity. | |
TH1701003495A (en) | Triazolopyrimidine and its use | |
TH1701001398A (en) | 1-alkyl-6-oxo-1,6-dihydropyridin-3-il compounds And using it as a SGRM controller | |
TH169613A (en) | NR2B selective Antagonist type | |
TH153190A (en) | Benzamide derivatives for inhibition of the inactivation of ABL1, ABL2 and BCR-ABL1. | |
TH146336A (en) | Pyridazinone compounds and their use as DAAO inhibitors | |
TH127350B (en) | Compounds of Formula I or any pharmaceutical acceptable salt or probak of that substance. And the use of them as drugs | |
TH1601006725A (en) | imidazo compound[4,5-C]quinolin-2-transfer and the use of those substances in cancer therapy |